Also trades as: LABS.TO (TSX) · $vol 0M
MEDIF OTC
MediPharm Labs Corp.
1W: +1.0%
1M: -3.6%
3M: +1.4%
YTD: +0.2%
1Y: -8.4%
3Y: -10.3%
5Y: -76.7%
$0.05
-0.00 (-3.40%)
Weekly Expected Move ±7.9%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$5M
+58.7% ▲
Capital Expenditures
$154K
+67.3% ▲
5Y CAGR: -65.7%
Free Cash Flow
-$5M
+59.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
-2.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$67M | -$55M | -$30M | -$13M | -$11M |
| Depreciation & Amort. | $11M | $6M | $3M | $3M | $3M |
| Stock-Based Comp. | $3M | $2M | $3M | $2M | $976K |
| Change in Working Capital | $17M | $22M | $6M | $3M | $2M |
| Other Non-Cash Items | $4M | $12M | $2M | -$4M | $605K |
| Operating Cash Flow | -$38M | -$13M | -$16M | -$12M | -$5M |
| — Investing Activities — | |||||
| Capital Expenditures | -$8M | -$783K | -$863K | -$471K | -$154K |
| Acquisitions (Net) | -$541K | $818K | $6M | $7M | $0 |
| Investment Purchases | -$2K | $0 | $0 | $0 | $0 |
| Investment Sales | $541K | $0 | $0 | $0 | $0 |
| Other Investing | $59K | $507K | $7K | $2M | $567K |
| Investing Cash Flow | -$7M | $35K | $5M | $7M | $413K |
| — Financing Activities — | |||||
| Net Debt Issuance | $22M | -$3M | $393K | -$944K | -$2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $4M | -$151K | $403K | $576K | $405K |
| Financing Cash Flow | $26M | $28M | $796K | -$944K | -$2M |
| Net Change in Cash | -$19M | $14M | -$10M | -$6M | -$6M |
| Cash End of Period | $20M | $34M | $24M | $18M | $12M |
| Free Cash Flow | -$45M | -$14M | -$17M | -$12M | -$5M |